Published in J Clin Endocrinol Metab on November 06, 2007
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril (2010) 2.25
Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev (2012) 1.05
Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2011) 0.97
Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes Care (2008) 0.88
Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample. Atherosclerosis (2008) 0.79
Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus. World J Exp Med (2015) 0.78
Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.77
Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.77
Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine. Ann Saudi Med (2010) 0.77
Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. J Clin Endocrinol Metab (2008) 0.75
Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome? Avicenna J Med (2016) 0.75
Comparison of Metformin and Simvastatin Administration in Women With Polycystic Ovary Syndrome Before Intra-Cytoplasmic Sperm Injection Cycle: A Prospective, Randomized, Clinical Trial Study. Iran Red Crescent Med J (2015) 0.75
Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: A PRISMA-compliant article. Medicine (Baltimore) (2017) 0.75
Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc (2012) 3.77
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study. Lancet (2012) 3.48
Short-term sleep loss decreases physical activity under free-living conditions but does not increase food intake under time-deprived laboratory conditions in healthy men. Am J Clin Nutr (2009) 3.20
The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab (2010) 3.12
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant (2010) 2.70
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer (2004) 2.20
Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med (2007) 2.17
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol (2005) 1.96
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. J Am Soc Nephrol (2007) 1.92
Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation (2005) 1.89
Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab (2006) 1.87
Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant (2007) 1.86
Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology (2006) 1.80
Hypoglycemia and cardiovascular risks. Diabetes Care (2011) 1.74
B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation (2010) 1.73
Postoperative hypocalcemia--the difference a definition makes. Head Neck (2010) 1.66
The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury. Crit Care Med (2007) 1.61
Disturbed glucoregulatory response to food intake after moderate sleep restriction. Sleep (2011) 1.55
A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol (2006) 1.54
First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol (2004) 1.53
Mitochondrial gene polymorphisms that protect mice from colitis. Gastroenterology (2013) 1.53
Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. Stroke (2013) 1.53
Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J (2004) 1.52
Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. J Am Coll Cardiol (2003) 1.51
Clinical review: Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab (2007) 1.51
Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care (2012) 1.49
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens (2004) 1.48
Platelet count and platelet activation: impact of a fat meal and day time. Platelets (2007) 1.46
In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun (2009) 1.45
Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab (2006) 1.45
Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol (2012) 1.44
High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens (2004) 1.43
The anti-atherogenic aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: role of the newly established pro-inflammatory adipokine Acute-phase Serum Amyloid A; evidence of an adipose tissue-monocyte axis. Atherosclerosis (2010) 1.43
Phaeochromocytoma, new genes and screening strategies. Clin Endocrinol (Oxf) (2006) 1.41
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab (2006) 1.41
T-wave variability for the prediction of fast ventricular arrhythmias – prospective, observer-blind study. Circ J (2014) 1.40
Interaction of tumor cells with the microenvironment. Cell Commun Signal (2011) 1.38
Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes (2008) 1.34
Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One (2012) 1.30
Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1. Mol Cancer (2011) 1.30
Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology (2010) 1.30
Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes. Diabetes Care (2002) 1.29
Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. BMC Genomics (2009) 1.29
Absence of CCR6 inhibits CD4+ regulatory T-cell development and M-cell formation inside Peyer's patches. Am J Pathol (2005) 1.29
Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study. Clin Immunol (2002) 1.27
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis (2006) 1.26
Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes (2009) 1.25
Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab (2007) 1.24
Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell Immunol (2003) 1.24
Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis (2005) 1.23
[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care]. Med Klin (Munich) (2006) 1.22
Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care (2002) 1.21
PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene (2003) 1.21
Circadian desynchrony promotes metabolic disruption in a mouse model of shiftwork. PLoS One (2012) 1.20
Simvastatin prevents vascular hyporeactivity during inflammation. Circulation (2004) 1.20
Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arterioscler Thromb Vasc Biol (2006) 1.18
Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes (2008) 1.18
Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Cardiovasc Res (2009) 1.17
Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) (2006) 1.17
Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. J Clin Endocrinol Metab (2003) 1.17
Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab (2008) 1.16
Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care (2007) 1.16
The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr (2006) 1.16
Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab (2005) 1.16
Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes. Diabetes (2009) 1.15
Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment. J Clin Psychopharmacol (2004) 1.15
Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes (2012) 1.12
Metastatic paraganglioma. Semin Oncol (2010) 1.12
Weight loss in obese patients with type 2 diabetes: effects of telemonitoring plus a diet combination - the Active Body Control (ABC) Program. Diabetes Res Clin Pract (2010) 1.12
Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. Invest Ophthalmol Vis Sci (2008) 1.10
Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal. Am J Cardiol (2006) 1.10
Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. J Clin Endocrinol Metab (2010) 1.09
Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control. Psychother Psychosom (2010) 1.09
Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol (2007) 1.08
Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care (2007) 1.07
Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes (2010) 1.07
Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure. Arterioscler Thromb Vasc Biol (2007) 1.07
Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications (2006) 1.06
Weight loss by telemonitoring of nutrition and physical activity in patients with metabolic syndrome for 1 year. J Am Coll Nutr (2014) 1.06
S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research. Psychoneuroendocrinology (2009) 1.06
Characterization and outcome following Puumala virus infection: a retrospective analysis of 75 cases. Nephrol Dial Transplant (2010) 1.05
Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev (2012) 1.05
The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care (2007) 1.05
Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest Ophthalmol Vis Sci (2009) 1.04
Effects of selective slow-wave sleep deprivation on nocturnal blood pressure dipping and daytime blood pressure regulation. Am J Physiol Regul Integr Comp Physiol (2009) 1.04
Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes (2003) 1.03